Medical Properties Trust (NYSE: MPT) closed Friday at $4.70, up 2.17% on the day and posting a 1.5% weekly gain. The healthcare real estate investment trust (REIT) is set to report second-quarter earnings before Monday's opening bell, with a conference call scheduled for 11 a.m. EDT. Investors are bracing for a critical test of the company's cash-flow resilience, as the stock's hefty 7.7% dividend yield hinges on its ability to generate sufficient cash to cover both payouts and debt obligations.
Consensus estimates project second-quarter funds from operations (FFO) of $0.15 per share, with revenue anticipated at $253.28 million. That would represent a 5.4% year-over-year increase in revenue, though only a 0.5% sequential gain. FFO, a key metric for REITs, is expected to climb 7.1% from the prior quarter. For the first quarter of 2026, MPT reported normalized FFO of $82.2 million, but operating cash flow was negative at $14 million, underscoring the gap between accounting earnings and actual cash generation.
The company's dividend, set at $0.09 per quarter, implies an annual yield of 7.7% based on Friday's close. At the headline level, the projected FFO of $0.15 would cover the quarterly dividend approximately 1.67 times, suggesting adequate coverage on an accrual basis. However, the negative operating cash flow raises questions about sustainability. In the first quarter, interest expenses climbed to $133.3 million, up from $115.8 million a year earlier, as the weighted average interest rate rose to 5.2% from 4.9%. These higher borrowing costs have offset gains in rental income, pressuring cash flow.
Refinancing Gap and Liquidity Bridge
MPT faces a significant refinancing challenge. As of May 6, the company had $1.00 billion in available liquidity, but a $1.112 billion principal payment is due on that date. Management plans to extend $524 million of its revolving credit facility into 2027, leaving approximately $588 million of principal to be addressed. The company estimates it will receive about $150 million from its stake in Infracore SA (SWX: INFRAC), a Swiss infrastructure company, which would cover roughly 25.5% of the remaining principal. These proceeds are earmarked for debt repayment and general corporate purposes.
Infracore's initial update on August 6 provided some reassurance. The company reported a 5.3% increase in rental income for the first half of the year, with operating cash flow of CHF20.2 million. Its net loan-to-value ratio improved to 42.8%, suggesting a stable underlying asset. However, the projected receipts from Infracore are still estimates, and MPT has cautioned that it cannot guarantee favorable terms on any additional liquidity measures, which could include asset sales, further borrowing, equity issuance, or another dividend cut.
Dividend Yield and Peer Comparison
MPT's 7.7% yield stands out in the healthcare REIT sector, significantly higher than peers. Ventas Inc. (NYSE: VTR) yields 2.14%, Healthpeak Properties (NYSE: DOC) offers 5.70%, and Omega Healthcare Investors (NYSE: OHI) yields 5.55%. The yield differential reflects a higher risk premium, as MPT's market capitalization of $2.81 billion is roughly one-fifth the size of Healthpeak and Omega. Management remains confident, with CEO Edward Aldag reiterating that the company expects to achieve annualized cash rent of at least $1 billion by the end of the year, according to Business Wire.
Analyst Sentiment and Risks
Analyst price targets for MPT are divided. According to FactSet, the average target is $5.50, implying a 17% upside from Friday's close, while the median target of $5 suggests just a 6.4% gain. Targets range from $4.50 to $8.00. The consensus recommendation remains 'Hold,' with ratings split among 2 buys, 2 holds, and 2 sells, though the number of analysts has changed over recent months.
Monday's earnings report will be scrutinized beyond FFO, with investors focusing on cash rent, operating cash flow, debt repayment progress, and any commentary on dividend policy. Key risks include tenant solvency, deferred rent, and refinancing costs. MPT has previously stated it may seek liquidity through asset disposals, additional borrowing, equity issuance, or revising its dividend again, but cautioned that terms may not be favorable. A result in line with expectations could support the yield case, but a sustainable re-rating likely hinges on solid cash conversion and clearer resolution of the debt maturity schedule.
